Page last updated: 2024-09-03

293b cpd and ziprasidone

293b cpd has been researched along with ziprasidone in 1 studies

Compound Research Comparison

Studies
(293b cpd)
Trials
(293b cpd)
Recent Studies (post-2010)
(293b cpd)
Studies
(ziprasidone)
Trials
(ziprasidone)
Recent Studies (post-2010) (ziprasidone)
1000161,068254362

Protein Interaction Comparison

ProteinTaxonomy293b cpd (IC50)ziprasidone (IC50)
D(2) dopamine receptorHomo sapiens (human)0.005
Aspartate aminotransferase, cytoplasmicHomo sapiens (human)5.39
DRattus norvegicus (Norway rat)0.1514
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)0.1514
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)0.1514
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)0.1514
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)0.1514
Alpha-1D adrenergic receptorHomo sapiens (human)0.011
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.0004
Alpha-1A adrenergic receptorHomo sapiens (human)0.011
Alpha-1B adrenergic receptorHomo sapiens (human)0.011
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.2301

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wermuth, CG1

Reviews

1 review(s) available for 293b cpd and ziprasidone

ArticleYear
Selective optimization of side activities: another way for drug discovery.
    Journal of medicinal chemistry, 2004, Mar-11, Volume: 47, Issue:6

    Topics: Animals; Biological Availability; Combinatorial Chemistry Techniques; Databases, Factual; Drug Design; Humans; Patents as Topic; Pharmaceutical Preparations; Structure-Activity Relationship

2004